BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 30952817)

  • 1. Deletion of Biliverdin Reductase A in Myeloid Cells Promotes Chemokine Expression and Chemotaxis in Part via a Complement C5a--C5aR1 Pathway.
    Bisht K; Canesin G; Cheytan T; Li M; Nemeth Z; Csizmadia E; Woodruff TM; Stec DE; Bulmer AC; Otterbein LE; Wegiel B
    J Immunol; 2019 May; 202(10):2982-2990. PubMed ID: 30952817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ras-Related Protein Rab5a Regulates Complement C5a Receptor Trafficking, Chemotaxis, and Chemokine Secretion in Human Macrophages.
    Wu KC; Condon ND; Hill TA; Reid RC; Fairlie DP; Lim J
    J Innate Immun; 2023; 15(1):468-484. PubMed ID: 36882040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The C5a/C5aR1 axis controls the development of experimental allergic asthma independent of LysM-expressing pulmonary immune cells.
    Wiese AV; Ender F; Quell KM; Antoniou K; Vollbrandt T; König P; Köhl J; Laumonnier Y
    PLoS One; 2017; 12(9):e0184956. PubMed ID: 28931049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid-mediated fibrosis is driven by C5a receptor 1-mediated activation of kidney myeloid cells.
    Sahu RK; Xavier S; Chauss D; Wang L; Chew C; Taylor R; Stallcup WB; Ma JZ; Kazemian M; Afzali B; Köhl J; Portilla D
    Am J Physiol Renal Physiol; 2022 Jun; 322(6):F597-F610. PubMed ID: 35379003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C5a/C5aR1 Pathway Is Critical for the Pathogenesis of Psoriasis.
    Zheng QY; Liang SJ; Xu F; Li GQ; Luo N; Wu S; Li Y; Tang M; Zhong Y; Chen J; Yang D; Sun DD; Zhang KQ; Xu GL
    Front Immunol; 2019; 10():1866. PubMed ID: 31447855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C5aR1 interacts with TLR2 in osteoblasts and stimulates the osteoclast-inducing chemokine CXCL10.
    Mödinger Y; Rapp A; Pazmandi J; Vikman A; Holzmann K; Haffner-Luntzer M; Huber-Lang M; Ignatius A
    J Cell Mol Med; 2018 Dec; 22(12):6002-6014. PubMed ID: 30247799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Netrin-1 Reduces Monocyte and Macrophage Chemotaxis towards the Complement Component C5a.
    Taylor L; Brodermann MH; McCaffary D; Iqbal AJ; Greaves DR
    PLoS One; 2016; 11(8):e0160685. PubMed ID: 27509208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections.
    Muenstermann M; Strobel L; Klos A; Wetsel RA; Woodruff TM; Köhl J; Johswich KO
    Virulence; 2019 Dec; 10(1):677-694. PubMed ID: 31274379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.
    Laumonnier Y; Karsten CM; Köhl G; Köhl J
    Curr Protoc Immunol; 2020 Sep; 130(1):e100. PubMed ID: 32710701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanoma.
    Nabizadeh JA; Manthey HD; Panagides N; Steyn FJ; Lee JD; Li XX; Akhir FNM; Chen W; Boyle GM; Taylor SM; Woodruff TM; Rolfe BE
    FASEB J; 2019 Oct; 33(10):11060-11071. PubMed ID: 31298935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of anaphylatoxin C5a on antigen presenting cells, roles for C5aR1 and C5aR2.
    Zaal A; van Ham SM; Ten Brinke A
    Immunol Lett; 2019 May; 209():45-52. PubMed ID: 30959077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Complement System Component C5a Produces Thermal Hyperalgesia via Macrophage-to-Nociceptor Signaling That Requires NGF and TRPV1.
    Shutov LP; Warwick CA; Shi X; Gnanasekaran A; Shepherd AJ; Mohapatra DP; Woodruff TM; Clark JD; Usachev YM
    J Neurosci; 2016 May; 36(18):5055-70. PubMed ID: 27147658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial ligand-receptor engagement yields functional bias at the human complement receptor, C5aR1.
    Pandey S; Li XX; Srivastava A; Baidya M; Kumari P; Dwivedi H; Chaturvedi M; Ghosh E; Woodruff TM; Shukla AK
    J Biol Chem; 2019 Jun; 294(24):9416-9429. PubMed ID: 31036565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bidirectional Crosstalk between C5a Receptors and the NLRP3 Inflammasome in Macrophages and Monocytes.
    Haggadone MD; Grailer JJ; Fattahi F; Zetoune FS; Ward PA
    Mediators Inflamm; 2016; 2016():1340156. PubMed ID: 27382187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C5a/C5aR1 axis promotes progression of renal tubulointerstitial fibrosis in a mouse model of renal ischemia/reperfusion injury.
    Peng Q; Wu W; Wu KY; Cao B; Qiang C; Li K; Sacks SH; Zhou W
    Kidney Int; 2019 Jul; 96(1):117-128. PubMed ID: 31029505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The C5a anaphylatoxin receptor (C5aR1) protects against Listeria monocytogenes infection by inhibiting type 1 IFN expression.
    Calame DG; Mueller-Ortiz SL; Morales JE; Wetsel RA
    J Immunol; 2014 Nov; 193(10):5099-107. PubMed ID: 25297874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C5a receptor1 inhibition alleviates influenza virus-induced acute lung injury.
    Song N; Li P; Jiang Y; Sun H; Cui J; Zhao G; Li D; Guo Y; Chen Y; Gao J; Sun S; Zhou Y
    Int Immunopharmacol; 2018 Jun; 59():12-20. PubMed ID: 29621732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Novel Receptor C5aR2 Is Required for C5a-Mediated Human Mast Cell Adhesion, Migration, and Proinflammatory Mediator Production.
    Pundir P; MacDonald CA; Kulka M
    J Immunol; 2015 Sep; 195(6):2774-87. PubMed ID: 26283482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement C5a-C5aR1 signalling drives skeletal muscle macrophage recruitment in the hSOD1
    Wang HA; Lee JD; Lee KM; Woodruff TM; Noakes PG
    Skelet Muscle; 2017 Jun; 7(1):10. PubMed ID: 28571586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelets promote CRC by activating the C5a/C5aR1 axis via PSGL-1/JNK/STAT1 signaling in tumor-associated macrophages.
    Li X; Chen X; Gong S; Zhao J; Yao C; Zhu H; Xiao R; Qin Y; Li R; Sun N; Li X; Dong F; Zhao T; Pan Y; Yang J
    Theranostics; 2023; 13(6):2040-2056. PubMed ID: 37064877
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.